Ioanna P. Chatziprodromidou

Dr. Ioanna P. Chatziprodromidou

Department of Medicine, Medical School University of Patras, Patras, Achaea, Greece
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
GVGavriela Voulgaridou
Gavriela Voulgaridou
Stefanos TyrovolasStefanos Tyrovolas
Stefanos Tyrovolas
Paraskevi DetopoulouParaskevi Detopoulou
Paraskevi Detopoulou
DTDespoina Tsoumana
Despoina Tsoumana
MDMariella Drakaki
Mariella Drakaki
Sousana PapadopoulouSousana Papadopoulou
Sousana Papadopoulou
Sarcopenia, a geriatric syndrome characterized by progressive skeletal muscle mass and function decline, poses a significant health risk among the elderly, contributing to frailty, falls, hospitalization, loss of independence and mortality. The prevalence of sarcopenia varies significantly based on various factors, such as living status, demographics, measurement techniques and diagnostic criteria. Although the overall prevalence is reported at 10% in individuals aged 60 and above, disparities exist across settings, with higher rates in nursing homes and hospitals. Additionally, the differences in prevalence between Asian and non-Asian countries highlight the impact of cultural and ethnic factors, and variations in diagnostic criteria, cut-off values and assessment methods contribute to the observed heterogeneity in reported rates. This review outlines diverse diagnostic criteria and several measurement techniques supporting decision making in clinical practice. Moreover, it facilitates the selection of appropriate tools to assess sarcopenia, emphasizing its multifactorial nature. Various scientific groups, including the European Working Group of Sarcopenia in Older People (EWGSOP), the International Working Group on Sarcopenia (IWGS), the Asian Working Group on Sarcopenia (AWGS), the American Foundation for the National Institutes of Health (FNIH) and the Sarcopenia Definition and Outcomes Consortium (SDOC), have published consensus papers outlining diverse definitions of sarcopenia. The choice of diagnostic criteria should be aligned with the specific objectives of the study or clinical practice, considering the characteristics of the study population and available resources.

22 February 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
Sousana PapadopoulouSousana Papadopoulou
Sousana Papadopoulou
Paraskevi DetopoulouParaskevi Detopoulou
Paraskevi Detopoulou
GVGavriela Voulgaridou
Gavriela Voulgaridou
DTDespoina Tsoumana
Despoina Tsoumana
MSMaria John Spanoudaki
Maria John Spanoudaki
Pantelis T. NikolaidisPantelis T. Nikolaidis
Pantelis T. Nikolaidis
Low muscle mass combined with changes in physical function and muscle quality is defined as sarcopenia. In people > 60 years, sarcopenia reaches 10% and tends to increase with age. Individual nutrients, such as protein, may have a protective role against sarcopenia, but recent evidence suggests that protein alone has been ineffective in increasing muscle strength. Dietary patterns, instead, with a high “anti-inflammatory” potential, such as the Mediterranean dietary pattern, have been considered as an emerging dietary remedy against sarcopenia. The aim of this systematic review was to summarize the evidence of the role of Mediterranean diet in sarcopenia prevention and/or improvement, including recent data, in healthy elders. We searched published studies about sarcopenia and the Mediterranean diet until December 2022 in Pubmed, Cochrane, Scopus search engine and grey literature. In total, ten articles were identified as relevant: four cross-sectional studies and six prospective. No clinical trial was identified. Only three studies assessed sarcopenia presence and four measured muscle mass, which is an essential criterion in sarcopenia diagnosis. Mediterranean diet adherence had, in general, a positive role in muscle mass and muscle function, while the results were less clear with regard to muscle strength. Additionally, there was no evidence of a positive effect of the Mediterranean diet on sarcopenia. There is a need for conduction of clinical trials in order to reach cause–effects conclusions regarding the importance of the Mediterranean diet in sarcopenia prevention and management in Mediterranean and non-Mediterranean populations.

14 March 2018 in Journal of Applied Microbiology
Verified
Journal Article
Closed access
PDF file
Ioanna P. ChatziprodromidouIoanna P. Chatziprodromidou
Ioanna P. Chatziprodromidou
MBMaria Bellou
Maria Bellou
GVGeorge Vantarakis
George Vantarakis
Apostolos VantarakisApostolos Vantarakis
Apostolos Vantarakis

11 October 2022 in Cells
Verified
Journal Article
Open access
PDF file
TKTHEODORA KATOPODI
THEODORA KATOPODI
SPsavvas petanidis
savvas petanidis
CCCharalampos Charalampidis
Charalampos Charalampidis
Ioanna P. ChatziprodromidouIoanna P. Chatziprodromidou
Ioanna P. Chatziprodromidou
PEPANAGIOTIS ESKITZIS
PANAGIOTIS ESKITZIS
Konstantinos PorpodisKonstantinos Porpodis
Konstantinos Porpodis
The tumor microenvironment plays a key role in progression of tumorigenesis, tumor progression, and metastasis. Accumulating data reveal that dendritic cells (DCs) appear to play a key role in the development and progression of metastatic neoplasia by driving immune system dysfunction and establishing immunosuppression, which is vital for tumor evasion of host immune response. Consequently, in this review, we will discuss the function of tumor-infiltrating DCs in immune cell signaling pathways that lead to treatment resistance, tumor recurrence, and immunosuppression. We will also review DC metabolism, differentiation, and plasticity, which are essential for metastasis and the development of lung tumors. Furthermore, we will take into account the interaction between myeloid cells and DCs in tumor-related immunosuppression. We will specifically look into the molecular immune-related mechanisms in the tumor microenvironment that result in reduced drug sensitivity and tumor relapse, as well as methods for combating drug resistance and focusing on immunosuppressive tumor networks. DCs play a crucial role in modulating the immune response. Especially, as cancer progresses, DCs may switch from playing an immunostimulatory to an inhibitory role. This article’s main emphasis is on tumor-infiltrating DCs. We address how they affect tumor growth and expansion, and we highlight innovative approaches for therapeutic modulation of these immunosuppressive DCs which is necessary for future personalized therapeutic approaches.

7 October 2024 in Medicina
Verified
Journal Article
Open access
PDF file
AKAthanasios Kyrkousis
Athanasios Kyrkousis
PIPARIS IAKOVIDIS
PARIS IAKOVIDIS
Ioanna P. ChatziprodromidouIoanna P. Chatziprodromidou
Ioanna P. Chatziprodromidou
DLDimitrios Lytras
Dimitrios Lytras
KKKostantinos Kasimis
Kostantinos Kasimis
GKGEORGIOS KOUTRAS
GEORGIOS KOUTRAS
Background and Objectives: Adolescent Idiopathic Scoliosis (AIS) affects individuals aged 10–18 years and is characterized by spinal deformity, three-dimensional axis deformation, and vertebral rotation. Schroth method exercises and braces have been shown to reduce the Cobb angle and halt spinal deformity progression. The aim of this study was to investigate the impact of a 12-month, supervised Schroth exercise program on scoliosis severity and quality of life in adolescents with AIS. Materials and Methods: Eighty adolescents with AIS (aged 10–17 years) were prescribed a brace and were divided into two groups. The intervention group followed a supervised Schroth exercise program three times a week for 12 months in addition to wearing a brace. The control group used only the brace. Outcomes included the Cobb angle of the main curvature and the sum of curves using radiography, the maximum angle of trunk rotation (ATR maximum, using a scoliometer), and quality of life with the Scoliosis Research Society-22 (SRS-22) questionnaire. Evaluations were conducted at baseline, after 12 months, and 6 months post-intervention. A multivariate analysis of covariance (MANCOVA) was used for statistical analysis (p-Value < 0.05). Results: The intervention group showed statistically significant improvement compared to the control group in the 12th month in Cobb angle (mean differences, 95% CI: −3.65 (−5.81, −1.53), p-Value < 0.001, Cohen’s d = 0.30), ATR maximum (mean differences, 95% CI: −3.05 (−3.86, −2.23), p-Value < 0.001, Cohen’s d = 0.74), and SRS-22 score (mean differences, 95% CI: 0.87 (0.60, 1.13), p-Value < 0.001, Cohen’s d = 0.58). Differences in ATR maximum and SRS-22 score remained significant at the 18-month measurement. No significant differences were found between groups in the sum of curves (p-Value > 0.05). Conclusions: A 12-month supervised Schroth exercise program in AIS patients undergoing brace treatment significantly improves scoliosis severity (Cobb angle and ATR maximum) and quality of life. Improvements were greater than those in shorter-duration studies, suggesting a linear dose–response relationship. Further clinical studies are needed to clarify the impact of long-term Schroth programs.

25 January 2018 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
Ioanna P. ChatziprodromidouIoanna P. Chatziprodromidou
Ioanna P. Chatziprodromidou
MAMalamatenia Arvanitidou
Malamatenia Arvanitidou
JGJavier Guitian
Javier Guitian
TATHOMAS APOSTOLOU
THOMAS APOSTOLOU
GVGeorge Vantarakis
George Vantarakis
Apostolos VantarakisApostolos Vantarakis
Apostolos Vantarakis
We conducted a systematic review to investigate avian influenza outbreaks and to explore their distribution, upon avian influenza subtype, country, avian species and other relating details as no comprehensive epidemiological analysis of global avian influenza outbreaks from 2010 to 2016 exists. Data was collated from four databases (Scopus, Web of Science Core Correlation, PubMed and SpringerLink electronic journal) and a global electronic reporting system (ProMED mail), using PRISMA and ORION systematic approaches. One hundred seventy three avian influenza virus outbreaks were identified and included in this review, alongside 198 ProMED mail reports. Our research identified that the majority of the reported outbreaks occurred in 2016 (22.2%). These outbreaks were located in China (13.6%) and referred to commercial poultry farms (56.1%). The most common subtype reported in these outbreaks was H5N1 (38.2%), while almost 82.5% of the subtypes were highly pathogenic avian influenza viruses. There were differences noticed between ProMED mail and the scientific literature screened. Avian influenza virus has been proved to be able to contaminate all types of avian species, including commercial poultry farms, wild birds, backyard domestic animals, live poultry, game birds and mixed poultry. The study focused on wet markets, slaughterhouses, wild habitats, zoos and natural parks, in both developed and developing countries. The impact of avian influenza virus seems disproportionate and could potentially burden the already existing disparities in the public health domain. Therefore, a collaboration between all the involved health sectors is considered to be more than necessary.